GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biomics Biopharma Ltd (ASX:BBM) » Definitions » Stock Based Compensation

Biomics Biopharma (ASX:BBM) Stock Based Compensation : A$0.00 Mil (TTM As of . 20)


View and export this data going back to 2017. Start your Free Trial

What is Biomics Biopharma Stock Based Compensation?

Biomics Biopharma's Stock Based Compensation for the six months ended in . 20 was A$0.00 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in . 20 was A$0.00 Mil.


Biomics Biopharma Stock Based Compensation Historical Data

The historical data trend for Biomics Biopharma's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomics Biopharma Stock Based Compensation Chart

Biomics Biopharma Annual Data
Trend
Stock Based Compensation

Biomics Biopharma Semi-Annual Data
Stock Based Compensation

Biomics Biopharma Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Stock Based Compensation for the trailing twelve months (TTM) ended in . 20 was A$0.00 Mil.


Biomics Biopharma Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Biomics Biopharma's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.


Biomics Biopharma (ASX:BBM) Business Description

Traded in Other Exchanges
N/A
Address
1 Macquarie Place, Level 36, Gateway Tower, Sydney, NSW, AUS, 2000
Biomics Biopharma Ltd is a near-clinical-stage biopharmaceutical company in developing and commercialising double stranded ribonucleic acid (dsRNA) based innovative products for unmet medical needs.

Biomics Biopharma (ASX:BBM) Headlines

No Headlines